Prelude Capital Management’s Adagene ADAG Stock Holding History

Prelude Capital Management’s Portfolio ADAG Stock Details ADAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-28,620	Closed	-$80.1K	–	1188
2024 Q1	$80.1K	Buy	+28,620	New	+$89.1K	﹤0.01%	1223

Other funds holding ADAG

WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCG

Catalina Capital Group Torrance, California $168M AUM 16.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's ADAG Position: Q2 2024 in Review

Prelude Capital Management sold out of Adagene (ADAG) in Q2 2024, closing a stake of 28,620 shares — an estimated $80.1K sold.

Prelude Capital Management first reported a position in ADAG in Q1 2024 and held it in 1 quarter. The position peaked at $80.1K in Q1 2024. 14 funds tracked by Wall St. Rank hold ADAG as of Q2 2024.

Prelude Capital Management reported no remaining Adagene position as of Q2 2024 after selling out during the quarter.
Prelude Capital Management sold 28,620 Adagene shares in Q2 2024, an estimated $80.1K.
Prelude Capital Management first reported a position in Adagene in Q1 2024 and held it in 1 quarter.
Prelude Capital Management's Adagene position peaked at $80.1K in Q1 2024.
14 funds tracked by Wall St. Rank held Adagene as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.